IRD - Opus Genetics, Inc.
0.8
0.040 5.013%
Share volume: 234,810
Last Updated: 04-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.76
0.04
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-13-2024 | 11-12-2024 | |
| Assets | ||||
| Total Assets | 51.844 M | 44.834 M | 40.389 M | |
| Current Assets | 51.844 M | 44.834 M | 40.389 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.194 M | 948.000 K | 1.468 M | |
| Short Term Investments | 5.000 K | 5.000 K | 3.000 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 47.161 M | 41.409 M | 36.632 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 51.844 M | 44.834 M | 40.389 M | |
| Total liabilities | 5.787 M | 4.198 M | 6.089 M | |
| Total current liabilities | 5.787 M | 4.198 M | 6.089 M | |
| Accounts Payable | 2.064 M | 634.000 K | 844.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 46.057 M | 40.636 M | 34.300 M | |
| Common stock | 134.629 M | 136.973 M | 138.163 M | |
| Retained earnings | -88.572 M | -96.337 M | -103.863 M |
